Clinigen Group Plc

Clinigen (CLIN)

Company name:Clinigen Group Plc
EPIC:CLINTrading Currency:GBX
Market Sector:AS50ISIN:GB00B89J2419
Market Segment:AMSMShare Type:DE
WWW Address: 0.1P
 Price Price Change [%] Bid Offer Open High Low Volume
 624.50 9.5 [1.54] 623.50 624.50 612.00 625.00 604.00 289,445
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 829.95 132.90 0.35 10.30 7.61 60.63 1.22 881.00 - 554.00

Clinigen Key Figures

(at previous day's close)
Market Cap.829.95m
Shares In Issue132.90m
Prev. Close615.00
PE Ratio60.63 
Dividend Yield1.22%
EPS - basic10.30p
Dividend PS7.61p
Dividend Cover1.35 
Cash Flow PS45.60p
Return On Equity (ROE)3.07%
Operating Margin4.48%
PEG Factor0.38 
EPS Growth Rate157.50%
Dividends PS Growth Rate13.58%
Net Debt553.30m
Gross Gearing60.98%
Quick Assets276.20m
Net Working Capital116.50m
Intangibles / Fixed Assets98.35%
Turnover PS379.46p
Pre-Tax Profit PS17.01p
Retained Profit PS3.39p
Cash PS107.68p
Net Cash PS-45.22p
Net Tangible Asset Value PS *-273.22p
Net Asset Value PS335.29p
Spread1.00 (0.16%) 

Clinigen Balance Sheet


Share Price Performance

Sample Period HighLow
1 week625.00593.00
4 weeks640.00579.50
12 weeks870.00560.00
1 year881.00554.00

Share Price Chart (5 years)

Clinigen Historic Returns

Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week612.0012.502.04593.000.45609.04
4 weeks617.007.501.22579.500.67603.16
12 weeks852.50-228.00-26.74560.001.16619.18
26 weeks755.50-131.00-17.34560.000.73658.18
1 year716.00-91.50-12.78554.000.57661.12
3 years1,037.00-412.50-39.78350.400.43747.75
5 years658.00-33.50-5.09350.400.41807.45

Clinigen Key Management Ratios

Clinigen Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio76.51 
PE Ratio60.63 
Tobin's Q Ratio 0.75 
Tobin's Q Ratio (excl. intangibles)2.83 
Dividend Yield1.22%
Market-to-Book Ratio1.86 
Price-to-Pre-Tax Profit PS36.72 
Price-to-Retained Profit PS184.43 
Price-to-Cash Flow PS13.70 
Price-to-Sales PS1.65 
Price-to-Net Tangible Asset Value PS-2.29 
Price-to-Cash PS5.80 
Net Working Capital PS87.66 
Price Pct to Working Capital PS7.12%
Earnings Yield1.65%
Average PE134.54 
Years in average5 
PE to PE average45.06%

Clinigen Financial Ratios

(Leverage Ratios)
Debt Ratio52.54%
Debt-to-Equity Ratio1.11 
Debt-to-Equity Ratio (excl. Intgbl)-1.36 
Debt-to-Equity Market Value0.59 
Net Gearing48.45%
Net Gearing (excl. Intangibles)166.01%
Gross Gearing60.98%
Gross Gearing (excl. Intangibles)208.94%
Gearing Under 1 Year17.79%
Gearing Under 1 Year (excl. Intgbl)60.97%
(Liquidity Ratios)
Net Working Capital to Total Assets10.20%
Current Ratio1.57 
Quick Ratio (Acid Test)1.36 
Liquidity Ratio0.70 
Cash & Equiv/Current Assets44.76%
(Solvency Ratios)
Enterprise Value1,180.05m
CFO/Attributable Profit4.42 
Total Debt/Equity Market Value0.84 
Total Debt/Sales1.38 
Total Debt/Pre-Tax Profit30.81 
Total Debt696.40m
Total Debt/Net Current Assets5.98%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs3 
Beta (60-Mnth)Beta (36-Mnth)

Clinigen Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)2.41%
Return On Assets (ROA)1.24%
Net Profit Margin2.72%
Assets Turnover0.46 
Return On Equity (ROE)3.07%
Return On Investment (ROI)1.56%
Dividend Payout Ratio73.88%
Plowback Ratio26.12%
Growth from Plowback Ratio0.81%
Net Income Of Revenues0.89%
(Asset Utilisation Multiples)
Shareholders Equity Turnover1.14 
Fixed Assets Turnover0.61 
Current Assets Turnover1.83 
Net Working Capital Turnover 
Inventory Turnover12.78 
(Other Operating Ratios)
Total Assets-to-Sales2.19 
Debt Collection Period89.06Days

Clinigen Dividends

Announcement DateTypeCurr.Dividend AmountPeriod StartPeriod EndEx DateRecord DatePayment DateTotal Dividend Amount
17 Sep 2020FinalGBX5.4630/06/201930/06/202005/11/202006/11/202002/12/20207.61
25 Feb 2020InterimGBX2.1501/07/201931/12/201919/03/202020/03/202017/04/2020-
19 Sep 2019FinalGBX4.7530/06/201830/06/201907/11/201908/11/201929/11/20196.70
27 Feb 2019InterimGBX1.9501/07/201831/12/201821/03/201922/03/201912/04/2019-
27 Sep 2018FinalGBX3.8430/06/201730/06/201808/11/201809/11/201830/11/20185.60
27 Feb 2018InterimGBX1.7601/07/201731/12/201722/03/201823/03/201812/04/2018-
28 Sep 2017FinalGBX3.4030/06/201630/06/201709/11/201710/11/201701/12/20175.00
15 Mar 2017InterimGBX1.6001/07/201631/12/201623/03/201724/03/201713/04/2017-
28 Sep 2016FinalGBX2.7030/06/201530/06/201603/11/201604/11/201625/11/20164.00
02 Mar 2016InterimGBX1.3001/07/201531/12/201517/03/201618/03/201608/04/2016-
22 Sep 2015FinalGBX2.3030/06/201430/06/201515/10/201516/10/201506/11/20153.40
03 Mar 2015InterimGBX1.1001/07/201431/12/201412/03/201513/03/201502/04/2015-
24 Sep 2014FinalGBX2.1030/06/201330/06/201415/10/201417/10/201407/11/20143.10
26 Feb 2014InterimGBX1.0001/07/201331/12/201305/03/201407/03/201428/03/2014-
25 Sep 2013FinalGBX2.0030/06/201230/06/201309/10/201311/10/201301/11/20132.60
27 Feb 2013InterimGBX0.6001/07/201231/12/201206/03/201308/03/201328/03/2013-

Clinigen Fundamentals

 30 Jun 2017 (GBP)30 Jun 2018 (GBP)30 Jun 2019 (GBP)30 Jun 2020 (GBP)
pre tax profit14.104.66%35.909.42%12.302.69%22.604.48%m
attributable profit3.801.26%27.407.19%5.201.14%13.702.72%m
retained profit-1.10-0.36%21.105.54%-2.50-0.55%4.500.89%m
eps - basic (p)3.30 22.90 4.00 10.30 
eps - diluted (p)3.20 22.50 4.00 10.20 
dividends per share5.00 5.60 6.70 7.61 

Clinigen Balance Sheet

 30 Jun 2017 (GBP)30 Jun 2018 (GBP)30 Jun 2019 (GBP)30 Jun 2020 (GBP)
 30 Jun 2017 (GBP)30 Jun 2018 (GBP)30 Jun 2019 (GBP)30 Jun 2020 (GBP)
fixed assets fixed assets3.300.72%6.801.02%13.601.28%13.401.17%m
intangibles intangibles332.5072.36%497.6074.59%811.9076.16%808.7070.81%m
fixed investments fixed investments9.702.11%6.600.99%8.700.82%0.200.02%m
current assets - other current assets - other--%--%--%--%m
stocks stocks16.703.63%21.303.19%35.403.32%43.503.81%m
debtors debtors69.5015.13%98.5014.77%113.0010.60%133.1011.65%m
cash & securities cash & securities27.806.05%36.305.44%83.507.83%143.1012.53%m
creditors - short creditors - short171.7037.37%113.8017.06%243.4022.83%203.2017.79%m
creditors - long creditors - long38.708.42%203.8030.55%384.3036.05%493.2043.19%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
ord cap, reserves ord cap, reserves249.1054.21%349.5052.39%438.4041.12%445.6039.02%m
prefs, minorities prefs, minorities--%--%--%--%m
NAV Basic- - - - 
NAV Diluted- - - - 

Clinigen Cash Flow Statement

30 Jun 2017 (GBP)30 Jun 2018 (GBP)30 Jun 2019 (GBP)30 Jun 2020 (GBP)
Operating CF46.1047.6068.3060.60m
Pre-Financing CF37.30-75.60-183.00-20.80m
Retained CF-0.508.8046.8057.10m

Clinigen Brokers

Broker infomation is not available for this class of stock.
ADVFN Advertorial
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20210805 12:50:40